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Eosinophils have long been thought to be effectors of immunity to helminths but have also been
implicated in the pathogenesis of asthma.  Patterns of cytokine production in the host may influence the
pathogenesis of these diseases by regulating the activities of eosinophils and other components of the
immune response.  Mice which constitutively over-express IL-5 have profound and life-long eosino-
philia in a restricted number of tissues.  Although eosinophils from IL-5 transgenics are functionally
competent for a number of parameters considered to be important in inflammation, untreated animals
are overtly normal and free of disease.  In addition, the responses of these animals when exposed to
aeroallergens and helminths present a number of apparent paradoxes.  Eosinophil accumulation in
tissues adjacent to major airways is rapid and extensive in transgenics exposed to the aeroallergen, but
even after treatment with antigen over many months these mice show no evidence of respiratory distress
or pathology.  Helminth-infected IL-5 transgenics and their non-transgenic littermates develop similar
inflammatory responses at mucosal sites and are comparable for a number of T cell and antibody re-
sponses, but they differ considerably in their ability to clear some parasite species.  The life-cycle of
Nippostrongylus brasiliensis  is significantly inhibited in IL-5 transgenics, but that of  Toxocara canis is
not.  Our results also suggest that eosinophilia and/or over-expression of IL-5 may actually impair host
resistance to Schistosoma mansoni and Trichinella spiralis.  The pathogenesis of diseases in which
eosinophils are involved may therefore be more complex than previously thought.
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Elevated levels of eosinophils are seen in the
blood and tissues of animals infected with some
invasive helminths, in asthmatics and some atopic
individuals, in idiopathic hypereosinophilia syn-
drome (IHES) and in a restricted range of other
diseases.  Eosinophils may be a prominent feature
at sites of inflammation in these diseases, though
other leukocytes may also be present in large num-
bers.  Eosinophils would seem to be well equipped
to provide protection against helminths.  They are
capable of antibody-dependent cytotoxicity for a
number of targets in vitro including the helminths
Schistosoma mansoni and Trichinella spiralis
(Butterworth 1984).  Eosinophils are thought to
damage parasites by releasing in their immediate
vicinity an array of pre-formed toxic granule pro-
teins including major basic protein (MBP), eosi-
nophil peroxidase and eosinophil cationic protein.
They may also rapidly generate and release toxic
or pro-inflammatory products such as platelet ac-
tivating factor (PAF) and leukotrienes.  Eosinophil-
mediated toxicity extends to mammalian target cells
in vitro and possibly also to cultured tissues such
as sections of trachea (Frigas et al. 1991).  It is
widely believed that asthma may in part be caused
by the mis-directed or aberrant actions of eosino-
phils recruited to the airways by chronic exposure
to antigen. To further investigate the roles of eosi-
nophils in parasitic infections and in allergic lung
diseases we have made extensive use of interleukin-
5 transgenic mice (Dent et al. 1990) originally de-
veloped at the National Institute for Medical Re-
search (NIMR, Mill Hill, UK) in the laboratory of
Colin Sanderson.  Our data are in some cases quite
surprising and not in keeping with widely held
views of the functions or eosinophils in disease.
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GENERAL BIOLOGY OF IL-5 TRANSGENICS
The CBA/Ca IL-5 transgenics used in these
studies were generated using a transgene which
imparts constitutive expression of IL-5 to CD2+
cells, most of which are T cells (Dent et al. 1990).
Expression of IL-5 could be very significantly en-
hanced by stimulation of T cells in vitro with con-
canavalin A and in vivo by infection with the hel-
minth Mesocestoides corti (Strath et al. 1992), sug-
gesting that the transgene is at least partially regu-
lated by genomic sequences native to IL-5 and in-
cluded in the transgene construct.  These animals
show life-long eosinophilia in the blood and in a
restricted range of tissues (Dent et al. 1990).  Apart
from splenomegaly, even transgenics with very
high transgene copy numbers are overtly normal,
and in particular, show no signs of respiratory dis-
tress.  B cell numbers and antibody profiles were
not markedly different from those seen in non-
transgenic littermates (Sanderson et al. 1994, Dent
& Sanderson, unpublished results).
One notable aberration which was detected
early in our studies relates to breeding success.
Three of the four founder transgenic lines
[Tg(0IL5)C1 (Tg1), Tg2 and Tg3 with approxi-
mately 8, 49 and 44 transgene copies respectively]
have been maintained as heterozygotes for more
than six years without major problems.  Litter sizes
are comparable to those seen in nontransgenic ani-
mals of the same strain but maintained under spe-
cific-pathogen-free conditions (mean litter size ±
standard deviation for the third litters of Tg1, Tg2,
Tg3 lines and a comparable nontransgenic colony
were 5.7 ± 1.8; 6.0 ± 1.8; 6.5 ± 1.5 and 5.5 ± 1.91
respectively with n = 10 - 17).  Despite our long-
term success in breeding heterozygotes, we have
not been able to successfully breed any but the low-
est transgene copy line (Tg1) as homozygotes and
even then the frequency of homozygotes gener-
ated is lower than expected.  The reasons for this
have yet be elucidated, but given that eosinophil
numbers in the rodent uterus change dramatically
during oestrus (Tchernitchin et al. 1974), and also
the association of MBP with pregnancy in humans
(Oxvig et al. 1993), excessive eosinophilia may
influence the outcome of pregnancies at any of
several stages.
FUNCTIONAL CHARACTERISTICS OF EOSINOPHILS
FROM IL-5 TRANSGENICS
Chronic eosinophilia in humans with IHES has
been associated with eosinophil dysfunction and
ultrastructural abnormalities (Tai & Spry 1976,
Henderson et al. 1988, Sokol et al. 1988).  We ad-
dressed the possibility that IL-5 transgenics might
not spontaneously develop respiratory disease
when kept in conventional conditions because of
abnormalities in many of the eosinophils which
they carry.  Much of this has recently been de-
scribed (Dent et al. 1997).  Eosinophils from IL-5
transgenics have many eosinophilic granules and
at least as many as those found in eosinophils re-
covered from untreated or parasite-infected
nontransgenic littermates (Dent et al. 1997).  Many
but not all of these granules have one or more elec-
tron dense bodies at the core, an ultrastructural fea-
ture typical of eosinophil granules (Fig. 1).
Fig. 1:  electronmicrograph of granules in a peripheral blood
eosinophil from a high transgene copy number (49 copies) Tg2
IL-5 transgenic mouse.  Most granules contain one or more of
the electron dense cores (arrow) typical of these organelles but
some granules appear to lack this structure (small arrow).  Eosi-
nophils from IL-5 transgenics have at least as many granules as
eosinophils isolated from the blood of non-transgenic littermates.
39,000x magnification.  Methods as described by Dent et al.
(1997).
Although not often noted as phagocytic cells,
we have found that eosinophils from IL-5
transgenics readily phagocytose yeast cells and
Gram-negative bacteria in the presence of normal
serum.  More than 80% of these eosinophils ph-
agocytose at least one yeast cell within 3 hr of in
vitro culture and this is not enhanced by addition
of immune serum.  Although on a cell-for-cell ba-
sis individual neutrophils from non-transgenic mice
appear to phagocytose more bacteria than eosino-
phils from IL-5 transgenics (unpublished data), we
have yet to determine if eosinophils can only kill
bacteria after internalization.  Regardless of their
principal method of killing, eosinophils from IL-5
transgenic mice compare in efficiency to neutro-
phils from non-transgenic mice in destroying
Gram-negative bacteria (Proteus mirabilis) op-
sonized with immune serum and both are more
efficient than eosinophils recovered from the site
of an M. corti infection in non-transgenic mice
(Dent et al. 1997).
Eosinophils from IL-5 transgenics also respond
in a dose-dependent manner to PAF in in vitro
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chemotaxis assays (Dent et al. 1997).  However
the real efficiency of recruitment of eosinophils
from IL-5 transgenics can best be illustrated in vivo.
Twenty four hours after a short exposure to aero-
solized ovalbumin, large perivascular leukocytic
infiltrates are evident in the lungs of immunized
IL-5 transgenics (Fig. 2).   The majority of these
cells are eosinophils and infiltrates are much more
substantial than those in similarly treated non-
transgenic littermates.  In time and with further
antigenic challenges the eosinophils will migrate
in large numbers to occupy the submucosa of the
airways.
expression of IL-5 and life-long eosinophilia do
not therefore appear to be sufficient for induction
of disease.  This then may reveal something criti-
cal about the roles of eosinophils in disease or at
least about signals which may direct their activi-
ties.  We have continued to investigate the biology
of these animals, and in particular to address the
roles of eosinophils in diseases in which these cells
are a prominent feature.  Our experiments have
yielded data which do not necessarily fit hypoth-
eses which are currently widely accepted.
HELMINTH INFECTIONS IN IL-5 TRANSGENICS
IL-5 transgenic mice have been experimentally
infected with a number of helminth species in our
laboratories.  In each case parasite burdens in het-
erozygous transgenic mice have been compared to
those in their non-transgenic littermates.  We have
found that over-expression of IL-5 and/or consti-
tutive eosinophilia may enhance resistance to some
but not all parasite species.  However, much to our
surprise, it seems that in some cases these compo-
nents of the anti-helminth response may actually
be disadavantageous (summarized in Table).
Fig. 2:  light micrograph of periarteriolar leukocyte infiltrate in
the lungs of an immunized Tg2 IL-5 transgenic mouse 24 hr after
a short exposure to an aerosol containing chicken ovalbumin
(OVA).  Infiltrates are evident at 24 hr but not at 4 hr post chal-
lenge and are usually asymmetrically oriented towards the near-
est airway.  Most of the leukocytes present are eosinophils.  After
repeated exposure to OVA eosinophils can also be found in the
sub-epithelial tissues of the airways and in the airways lumen.
Mice were immunized twice (Day 0 and Day 12) by ip. injection
with 10 µg of OVA (Sigma, Fraction V, 98% purity) mixed with
1 mg of alumina gel (Sigma) and saline to a total volume of 0.1
ml.  Animals were held in a closed box and given a single five
minute exposure to an aerosol of OVA (1% in saline, generated
with a clinical nebulizer) on Day 24.  Animals were sacrificed 24
hr after aerosol challenge.  60x magnification, parafin-embed-
ded section stained with haematoxylin and eosin.
Since IHES has been associated with a range
of disease syndromes in humans, if eosinophils in
IL-5 transgenic mice are fully functional, one might
also expect a similar outcome.  Over-expression
of other cytokine genes in mice (eg. GM-CSF and
IL-4) has been reported to cause progressive and
debilitating disease which is apparently a conse-
quence of the proliferation and activation of my-
eloid cells (Lang et al. 1987).  The data presented
above suggested to us that eosinophils in IL-5
transgenics are functionally competent.  With the
possible exception of impaired reproductive suc-
cess at very high levels of transgene expression,
IL-5 transgenics are essentially disease-free when
housed in conventional conditions.  Constitutive
TABLE
Summary of outcomes of helminthic infections in IL-5
transgenic mice
Parasite species Infection Parasite burden
compared with non-
transgenic littermates
Schistosoma mansoni Primary Increased
Secondary Increased
Trichinella spiralis Primary Increased
Toxocara canis Primary Comparable
Mesocestoides corti Primary Comparable
Nippostrongylus Primary Decreased
brasilisensis Secondary Comparable
Our first surprise came from studies conducted
at NIMR with the trematode S. mansoni.  Whilst
some data now suggest that IL-5 and eosinophils
are not important in mice for immunity to this hel-
minth (Sher et al. 1990a,b),  at the time that our
experiments were begun, the only published data
suggested that eosinophils may be a significant ef-
fector cell population (Butterworth et al. 1975,
Mahmoud et al. 1975).  We have shown that IL-5
transgenic animals have higher numbers of liver-
stage S. mansoni larvae than their non-transgenic
counterparts in both primary and secondary infec-
tions (Dent et al. 1997).  Although vaccination
appears to enhance clearance in transgenic animals,
multiple vaccinations do not alter the overall ef-
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fect of enhanced parasite survival in transgenic
mice.  S. mansoni would therefore appear either to
derive some advantage from over-expression of IL-
5 and/or eosinophilia, or alternatively, such a bias
in the immune response in some way impairs other
more protective components.
In support of this outcome, we have also ob-
served that, relative to their non-transgenic litter-
mates, larval burdens were also higher in transgenic
mice given a primary infection of the nematode T.
spiralis (Fig. 3).  However this is not a feature com-
mon to all nematode infections since Toxocara
canis fared neither better nor worse in IL-5
transgenic mice and larval migration patterns were
unaltered (Parsons, Dent et al. unpublished results).
Although it has proven difficult to accurately quan-
titate parasite numbers in animals injected ip. with
the cestode M. corti, the resulting infections fol-
low the same protracted, and ultimately fatal course
in IL-5 transgenic mice as they do in non-transgenic
littermates (Strath et al. 1992).
duce eggs (Fig. 4).  Those worms which do make
it to the gut fail to thrive and egg production, al-
ways a very transient event in mice, is virtually
non-existent in IL-5 transgenic animals (Fig. 5).
Few if any eggs have been detected in faeces from
transgenics in any of the many experiments we
have performed.  This parasite is then, unlike the
species described above, likely to be very severely
affected by over-expression of IL-5 and/or the sub-
sequent eosinophilia which meets the incoming
larvae.  Whilst larvae may be adversely affected in
the gut via eosinophil-related mechanisms, we have
evidence to suggest that much of the damage is
done to the parasite before it arrives in the gut or
even the lungs (Dent et al. unpublished results).
We also have data (not shown) to suggest that at
least one other nematode which makes a quick tran-
sit through its rodent host may also be more ad-
versely affected in IL-5 transgenics than in non-
trangenic mice.
We could speculate for some time on mecha-
nisms which might explain the impaired resistance
Fig. 3:  recovery of tissue-dwelling Trichinella spiralis from
mice ten days after primary infection by gavage with 200 lar-
vae.  Low transgene copy number Tg1 mice (8 copies) had a
signficantly higher parasite burden than similarly infected non-
transgenic littermates (p < 0.01, Mann-Whitney U test, 7 mice/
group).
On the basis of this evidence then, constitutive
expression of IL-5 and eosinophilia would not ap-
pear to be beneficial and may even be harmful to
the host in infections with a wide range of helmin-
thic species.  However this is not universally so.
For example, survival of the nematode
Nippostrongylus brasiliensis, a parasite with a very
short transit time in mice, is very significantly cur-
tailed in IL-5 transgenic animals.  Relatively few
larvae survive the transition from the subcutane-
ous injection site to the lungs, and then finally to
the small intestine, where they would normally
undergo further maturation, mate and begin to pro-
Fig. 4: IL-5 transgenic mice are more resistant to
Nippostrongylus brasiliensis  than their non-transgenic coun-
terparts.  Data are presented as the mean number of N.
brasiliensis worms/mouse from 3 to 11 days post subcutaneous
injection of 500 L3-stage larvae. Significantly more larvae were
recovered from non-transgenic CBA/Ca mice (open bars) than
Tg2 IL-5 transgenics (hatched bars).  * = p < 0.01, Student’s t
test, 3 - 4 mice/group/day.  The entire intestine was removed,
opened longitudinally and incubated in saline for at least  1hr
under a heat lamp.  Most worms migrated out of the intestine,
but worms remaining adherent to the gut were also counted.  A
dissecting microscope was used to aid counting of all worms
visible in each sample.  The animals tested correspond to those
depicted in Fig. 5.  The parasite was maintained by passage in
DA rats.
*
*
*
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seen in IL-5 transgenics infected with some of the
helminth species listed above.  For example, eosi-
nophils may be more than just simple killer cells -
they may also contribute to infections and inflam-
mation in other ways.  They may act as a source of
a number of cytokines, some of which, such as
transforming growth factor-β (Wong et al. 1991),
can be anti-inflammatory or immunoregulatory via
their effects on macrophages and lymphocytes.
Prostaglandins produced by eosinophils may also
inhibit inflammation (Hubsher 1975).  Even eosi-
nophil-specific proteins such as MBP which have
previously been described as toxic for parasites and
mammalian tissues, may also be anti-inflammatory
in their pro-form or when bound to other proteins.
Alternatively, an IL-5 bias may affect other arms
of anti-helminthic immune responses in ways
which have yet to be defined.  Of the known ef-
fects of IL-5 not directly relevant to eosinophils,
most of the likely parameters would not seem to
be greatly different between IL-5 transgenic mice
and their wild-type counterparts (reviewed in
Sanderson 1992, Dent et al. 1997).  We are there-
fore likely to be detecting either an activity not
previously attributed to IL-5, or an indirect effect
of this cytokine which is mediated by eosinophils.
Our results with N. brasiliensis are more in
keeping with the commonly perceived role of eosi-
nophils as effectors of anti-parasite immunity.  They
are also in concordance with results from experi-
ments in which IL-5 depletion led to enhancement
of infections with Strongyloides venezuelensis
(Korenaga et al. 1991) or Angiostrongylus
cantonensis (Yoshimura et al. 1994).  In this con-
text, it may be worth noting that both of these para-
sites are at least distantly related to N. brasiliensis.
So why should some parasites be detrimentally
affected by eosinophils and others not?  Further,
why should infections with some parasite species
appear to be worse in IL-5 transgenic mice?  The
answers to both questions almost certainly relate
to the biology and adaptions of individual parasite
species.  N. brasiliensis normally produces eggs
and leaves (or is expelled from) the host within ten
days of infection.  Changes in the number of eosi-
nophil precursors present in the bone marrow of
parasite-infected mice are not detected until ap-
proximately seven days after initiation of the in-
fection (Strath & Sanderson 1986).  By the time
new eosinophils are generated in the bone marrow
in response to the parasite, it has already mated
and begun to produce eggs.  Whilst some eosino-
phils may be recruited from the tissue pool before
this time, either they may not be available in large
numbers or they may not be able to localize to the
parasite as it moves rapidly through host tissues
and organs.  This parasite has not been forced to
live in the presence of large numbers of eosino-
phils and may therefore not have evolved such that
it has defences which can adequately counter this
cell.  Consequently, when confronted with large
numbers of eosinophils soon after injection into
IL-5 transgenic hosts, many of the larvae may be
rapidly overwhelmed.  On the other hand, para-
sites such as S. mansoni, T. spiralis and T. canis all
spend periods of months and even years in the host.
It would therefore be important for their survival
that they can efficiently counteract host defences
of many kinds, including eosinophils.  Indeed,
many examples of immune evasion mechanisms
adopted by helminths have been documented.
More specifically, a broad range of microbes have
recently been shown to utilize cytokine pathways
in a variety of ways to subvert host defences.  S.
mansoni has apparently taken this one step further
by utilizing tumour necrosis factor-α as a fecun-
dity-enhancing factor (Amiri et al. 1992).  It there-
fore seems possible that long-term tissue-dwell-
ing parasites might not only evade eosinophil-me-
diated defences, but could also utilize IL-5 and/or
eosinophil-derived factors for survival.  This would
seem to be the ultimate in parasitism.
Fig. 5:  production of eggs by Nippostrongylus brasiliensis  in-
fecting Tg2 IL-5 transgenic mice is negligible.  Three faecal
pellets were collected from each of three mice/group and eggs
were concentrated by flotation on saturated NaCl solution and
counted using a McMasters slide chamber.  Values represent
mean eggs/faecal pellet for each group.  In this experiment eggs
were only recovered from non-transgenic mice (open bars).
Arrowheads represent nil eggs detected for NTg (closed) and
Tg2 (open).  Mice were infected by subcutaneous injection with
500 L3-stage larvae.  The animals tested correspond to those
depicted in Fig. 4.
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RESPONSES OF IL-5 TRANSGENIC MICE TO AN
AEROALLERGEN
Asthma is characterized by (i) airways
hyperresponsiveness (AHR), (ii) inflammation in
which eosinophils are often a feature and (iii) tis-
sue damage, which may include loss of airways
epithelium, deposition of sub-epithelial collagen
and plugging of the airways.  Eosinophils are
present in large numbers in the lungs of untreated
IL-5 transgenic mice, but most are to be found in
the alveolar capillaries (Dent et al. 1990) and they
may also be found in smaller numbers associated
with lymphoid nodules of the upper airways.  We
found no other symptoms of asthma-like disease
in IL-5 transgenic mice kept under conventional
conditions.  As shown above (Fig. 1), even small
doses of ovalbumin can rapidly induce eosinophilia
in the lungs of transgenic mice, but again without
evidence of tissue damage.  Various protocols have
been used to induce tissue damage in these IL-5
transgenics, both in our own laboratory and by oth-
ers (Lefort et al. 1996).  We have found that tissue
eosinophilia is maintained throughout three months
of regular exposure to allergen (5 min exposure to
a 1% OVA in saline aerosol, twice weekly).  Eosi-
nophils made up the majority of cells occupying
the subepithelial tissues and some partially
degranulated cells could be detected by electron
microscopy in the immediate vicinity of the smooth
muscle adjacent to major airways (Fig. 6a, b).
However no tissue damage was detected in any of
the transgenic or non-transgenic animals sampled
at fortnightly intervals throughout these long-term
exposure experiments.
We have also used a more short-term but very
intensive exposure regime which has been shown
by others to induce tissue damage and AHR in
C57BL/6 mice (Foster et al. 1996).  Immunized
animals were exposed to OVA aerosols for three
30 min periods every second day over eight days.
Non-transgenic animals immunized twice with
OVA and challenged on four days with an aerosol
of saline alone, as expected, showed little evidence
of perivascular or peribronchial leukocytic infil-
trates (Fig. 7a).  When aerosols contained OVA,
vast numbers of eosinophils were recruited into
tissues immediately adjacent to both major and
minor airways of immunized IL-5 transgenics (Figs
7b, c, 8), and to a lesser extent, in non-transgenic
animals given the same treatment (Figs 7d, e, 8).
Whilst other leukocytes were present, most of the
cells were eosinophils. Twenty four hours after the
last OVA aerosol challenge eosinophils were also
recovered from the airways by bronchoalveolar la-
vage (Fig. 9) and represented 80% of the 3.7 x 107
leukocytes isolated per IL-5 transgenic animal
(mean value, compared with mean of 3.8 x 105 leu-
kocytes for similarly treated non-transgenics).  In
none of the animals immunized and challenged
with OVA could we find evidence of sloughing of
epithelial sheets, thickening of the sub-epithelial
“basement membrane” of the airways or obstruc-
tion of the airways by mucoid plugs containing
cellular debris.  We have not measured AHR in
these IL-5 transgenic mice but this has been done
by Lefort et al. (1996).  Whilst aerosol challenge
with OVA induces increased airways resistance in
Swiss mice treated with serotonin, the same effect
cannot be duplicated in either IL-5 transgenics or
non-transgenic CBA controls.  We therefore con-
Fig. 6:  photoelectronmicrograph of partially degranulated eosi-
nophils immediately adjacent to the smooth muscle (m) and epi-
thelium (e) of a major airway in the lung of a high copy number
(44 copies) Tg3 IL-5 transgenic mouse. The animal was immu-
nized twice with OVA and challenged for 5 min twice weekly
for two weeks (ie. a total of four exposures to OVA aerosols,
using an expansion of the protocol described in Fig. 2).  Lungs
were removed 24 hr after the last challenge.  Eosinophils (Fig.
6a; large arrows) can be identified by their few remaining eosi-
nophilic granules (Fig. 6b; small arrows).  1,300x and 4,800x
magnification for a and b respectively.  Other methods as de-
scribed by Dent et al. (1997).
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clude that even in primed animals exposed to large
doses of antigen or to smaller doses given over a
long period of time, constitutive eosinophilia does
not predispose CBA/Ca mice to the development
of asthma-like disease.
The roles that cytokines and leukocytes might
play in inducing AHR in mice has been a contro-
versial issue over a number of years.  The differ-
ences in the published data (Eum et al. 1995,
Iwamoto & Takatsu 1995, Corry et al. 1996, Fos-
Fig. 7:  photomicrographs of lung tissue sections prepared from mice given intensive exposure to OVA (or saline) aerosols over
eight days.  Mice were immunized and challenged as described in Fig. 2 except that OVA (or saline) aerosol challenges were given
in three 30 min sessions (ie. a total of 1.5 hr exposure/day) on each of Days 24, 26, 28 and 30.  Lungs were removed 24 hr after the
last challenge.  Sections presented are all of lower bronchioles but are consistent with findings in upper bronchioles, bronchi and
trachea of the same animals.  OVA immunized non-transgenic mice exposed to saline aerosols (a, 24x magnification) showed little
evidence of leukocyte infiltrates and those small foci sometimes detected were usually devoid of eosinophils.  Extensive leukocyte
infiltrates adjacent to all major airways were evident in Tg2 IL-5 transgenic mice immunized and challenged with OVA (b, 24x
magnification) but not in immunized transgenic mice challenged with saline only (not shown, but similar to a).  Many of the cells
in these infiltrates were readily identifiable as eosinophils (c, arrows, 240x magnification).  A similar though less extensive pattern
was also evident in OVA immunized and challenged non-transgenic CBA mice (d, 24x magnification, and e, 240x magnification).
In all animals, both transgenic and non-transgenic, airways were free of debris and the epithelium remained intact (c and e).
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others suggest that eosinophils may protect the host
against some but not all helminth species.  Our own
results also suggest that the presence of high lev-
els of IL-5 and/or eosinophilia in some way im-
pedes destruction of at least two species of inva-
sive helminths which both typically induce the pro-
duction of eosinophils.  Parasites which dwell in
the host for long periods of time are likely to have
evolved evasion mechanisms which negate the
actions of eosinophils.  They may also have taken
parasitism a step further such that they utilize com-
ponents of the immune response for their own ben-
efit - this may include either IL-5 or eosinophil
products.
When considering the role of eosinophils in
Fig. 8: the number of eosinophils infiltrating sub-epithelial bron-
chiolar tissues of Tg2 IL-5 transgenic mice (closed circles) and
their wild-type counterparts (open circles) after immunization
and intensive challenge with OVA (protocol as described in Fig.
7) increases with the number of challenges, and possibly also
with time elapsed after the initial challenge.  Eosinophils were
counted for each of two animals/group/timepoint in ten sepa-
rate 1 mm. linear segments of bronchiole to a depth of 100 µm
from the epithelial basement membrane.  Data presented are
means of mean sectional counts for each animal.  A similar
pattern was evident in both bronchi and trachea (data not shown).
Tissue sections analyzed were similar to those shown in Fig. 7
and areas were defined using a calibrated eyepiece graticle.
Fig. 9:  recovery of leukocytes by bronchoalveolar lavage (BAL)
from the airways of mice challenged with aerosols containing
OVA or saline (protocols as described in Fig. 7).  BAL was
performed 24 hr after the last aerosol challenge.  Immunization
and challenge with OVA (OVA/OVA) resulted in the recruit-
ment of large numbers of leukocytes into the airways (open
bars), the majority of which were eosinophils (closed bars) in
both Tg2 IL-5 transgenics (TG2) and non-transgenic (NTG)
littermates.  Immunization alone (OVA/-) or OVA aerosol chal-
lenge alone (-/OVA) had minimal effect on the cellular compo-
sition of the airways relative to untreated (-/-) animals. The
number of leukocytes recovered from NTG OVA/OVA mice
was double that from untreated or OVA/- NTG groups and most
of this change could be accounted for by an increase in eosino-
phils.  Approximately one hundred-fold more eosinophils were
recruited in transgenic than in non-transgenic animals (note log10
scale) and yet similarly treated animals (TG2 and NTG) did not
develop any evidence of airways damage (see Fig. 7).  BAL
was performed with 3 x 1ml volumes of PBS delivered and
recovered with a syringe and modified needle.  Cells were enu-
merated with a haemocytometer and differentiated using
Cytospin (Shandon) preparations stained with Giemsa (200 cells/
slide), 3 mice/group.
ter et al. 1996, Lefort et al. 1996) regarding the
roles of eosinophils and IL-5 in asthma have yet to
be satisfactorily reconciled.  We have no doubt
added to this dilemma, but own preliminary data
from comparative studies (not presented) and the
work of others (DeSanctis et al. 1995), suggest to
us that there may be substantial differences between
mouse strains in susceptibility to AHR and
aeroallergen-induced tissue damage.  Although IL-
4, IL-5, eosinophils and a number of other factors
have been proposed as key components in the de-
velopment of antigen-induced AHR, it is likely that
the effects of each of these factors can be very sub-
stantially modified by the genetic background of
the animals tested.  In the next few years we are
should see greater clarification of what these back-
ground factors might be.  Certainly even rampant
eosinophilia is not of itself sufficient for the devel-
opment of asthma.
CONCLUSIONS
In studying the roles of eosinophils in both
immunity to pathogens and in allergic disease, we
have been forced to re-assess the current dogma
on a number of issues.  Our own data and that of
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asthma, perhaps we might gain from the following
analogy.  If we were to examine the scene of a fire
from a single snapshot, it is likely that we would
be wrong in assuming that the fellows with the
hoses attached to the red trucks were responsible
for initiating the blaze.  Eosinophils are often found
in the lungs of asthmatics and indeed there is a
substantial body of experimental evidence which
suggests that under some conditions they may con-
tribute to the pathogenesis of the disease.  How-
ever much of the evidence is circumstantial.  The
logic often flows as follows: eosinophils can cause
damage and they are present in large numbers
where damage is manifested, therefore they are
responsible for the damage.  Firemen can light fires
as well as put them out, and sometimes they do
just that.  However this is not usually a suitable
explanation of the events captured in our snapshot
of the conflagration.  In our experimental studies
of the roles of eosinophils in asthma we have es-
tablished that even very spectacular eosinophilia
is not sufficient to lead to allergen-induced lung
disease.  In the future we should focus on the as
yet unknown genetically determined characteris-
tics which regulate the ways in which eosinophils
might contribute in asthma.  The interplay between
IL-5, eosinophils and other factors which can po-
tentiate disease is likely to be complex and so many
avenues for effective therapy of this disease have
yet to be explored.
Our two-pronged approach to the study of eosi-
nophils has again focused our thoughts on the like-
lihood that eosinophils cannot simply be classified
as end-stage effector cells or killers of microbes
which occasionally misbehave and end up damag-
ing the host unnecessarily.  We must seriously con-
sider the many products that eosinophils can se-
crete both in terms of their effects on microbial
targets and the surrounding tissues, but also on
other cells of the immune system.  We must ad-
dress the possibilities that there are subsets of eosi-
nophils with different functions or that eosinophils
may respond very differently depending upon the
stimuli received.  Eosinophils may be highly effi-
cient killers which are also capable of contribut-
ing to tissue damage, but they may also play a role
in tissue repair and even in immunoregulation.
Cells found at sites of inflammation are not neces-
sarily always contributing in a positive way to in-
flammation and it is possible that under some cir-
cumstances eosinophils or at least a subpopulation
of these cells may negatively regulate inflamma-
tion.  In the case of asthma, this could be benefi-
cial to the host whereas for some parasitic infec-
tions, or for the mixed infections often encountered
in the “real world”, this may be either advantageous
or detrimental.
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